B6J.129S2-Ncoa6tm1.2Ics/Ics

Status

Available to order

EMMA IDEM:12925
International strain nameB6J.129S2-Ncoa6tm1.2Ics/Ics
Alternative nameRAP-250 KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolNcoa6tm1.2Ics
Gene/Transgene symbolNcoa6

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationFor detailed information on the genetic description of this strain, please have a look at this report.
Phenotypic informationHomozygous:
not known

Heterozygous:
not known
Breeding history12 backcross generations
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased total body fat amount / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
  • abnormal retina morphology / IMPC
MGI phenotypes (gene matching)
  • abnormal triglyceride level / MGI
  • abnormal vascular development / MGI
  • abnormal heart morphology / MGI
  • abnormal heart development / MGI
  • thin ventricular wall / MGI
  • trabecula carnea hypoplasia / MGI
  • decreased hair follicle number / MGI
  • oligodactyly / MGI
  • abnormal liver development / MGI
  • abnormal liver morphology / MGI
  • small liver / MGI
  • decreased hepatocyte number / MGI
  • abnormal hepatocyte morphology / MGI
  • dilated third ventricle / MGI
  • abnormal hypothalamus morphology / MGI
  • abnormal brain development / MGI
  • thick epidermis / MGI
  • abnormal lens morphology / MGI
  • cataract / MGI
  • small lens / MGI
  • abnormal eye pigmentation / MGI
  • abnormal blood vessel morphology / MGI
  • decreased embryo size / MGI
  • abnormal placenta morphology / MGI
  • abnormal placenta development / MGI
  • impaired wound healing / MGI
  • delayed brain development / MGI
  • reduced male fertility / MGI
  • reduced female fertility / MGI
  • female infertility / MGI
  • decreased litter size / MGI
  • abnormal digit morphology / MGI
  • abnormal lipid homeostasis / MGI
  • disorganized myocardium / MGI
  • thin myocardium / MGI
  • heart hypoplasia / MGI
  • delayed wound healing / MGI
  • increased liver weight / MGI
  • abnormal epicardium morphology / MGI
  • abnormal vitelline vasculature morphology / MGI
  • abnormal placenta vasculature / MGI
  • abnormal embryonic hematopoiesis / MGI
  • absent placental labyrinth / MGI
  • absent olfactory bulb / MGI
  • abnormal fetal cardiomyocyte proliferation / MGI
  • pallor / MGI
  • abnormal feces composition / MGI
  • increased hepatocyte apoptosis / MGI
  • embryonic growth retardation / MGI
  • thin myocardium compact layer / MGI
  • abnormal spongiotrophoblast layer morphology / MGI
  • dilated vasculature / MGI
  • abnormal trophoblast layer morphology / MGI
  • increased circulating cholesterol level / MGI
  • abnormal heart ventricle morphology / MGI
  • pericardial effusion / MGI
  • abnormal myocardium layer morphology / MGI
  • abnormal bile salt homeostasis / MGI
  • reproductive system phenotype / MGI
  • abnormal cell physiology / MGI
  • impaired placental function / MGI
  • abnormal fetal cardiomyocyte morphology / MGI
  • abnormal placental labyrinth vasculature morphology / MGI
  • decreased neuron number / MGI
  • abnormal spongiotrophoblast cell morphology / MGI
  • decreased erythroid progenitor cell number / MGI
  • increased trophoblast giant cell number / MGI
  • decreased birth weight / MGI
  • decreased birth body size / MGI
  • abnormal palatal shelf fusion at midline / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • decreased fibroblast proliferation / MGI
  • decreased spongiotrophoblast size / MGI
  • abnormal liver bud morphology / MGI
  • increased sebaceous gland number / MGI
  • increased fibroblast apoptosis / MGI
  • small thalamus / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).